mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.7 |
mRNA |
AZD6244 |
FIMM |
pan-cancer |
AAC |
-0.074 |
0.7 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |